UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Overcoming limitations in current measures of drug response may enable AI-driven precision oncology

NPJ precision oncology, 2024-04, Vol.8 (1), p.95-95

2024

Link zum Volltext

Verfügbarkeit prüfen

ScLinear predicts protein abundance at single-cell resolution

Communications biology, 2024-03, Vol.7 (1), p.267-267

2024

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Mechanisms of microenvironment governed plasticity and progression in solid tumors

Frontiers in cell and developmental biology, 2024, Vol.12, p.1373496-1373496

2024

Link zum Volltext

Verfügbarkeit prüfen

Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells

Frontiers in oncology, 2023-08, Vol.13, p.1212585-1212585

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union

Gene, 2023-07, Vol.874, p.147481-147481, Article 147481

2023

Link zum Volltext

Verfügbarkeit prüfen

Minor intron splicing is critical for survival of lethal prostate cancer

Molecular cell, 2023-06, Vol.83 (12), p.1983-2002.e11

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumour mutations in long noncoding RNAs enhance cell fitness

Nature communications, 2023-06, Vol.14 (1), p.3342-3342, Article 3342

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A044: Generation of a new mouse model to study the role of oncofetal Cripto in aggressive lethal prostate cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.A044-A044

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B008: Tumor-stromal 3D co-cultures to study the role of cancer-associated fibroblasts in the acquisition of androgen-deprivation therapy resistance in prostate cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.B008-B008

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B007: New generation mTOR blocker sensitizes prostate cancer models to AR-targeting therapy

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.B007-B007

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract IA014: Drug sensitivity of multifocal primary prostate cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.IA014-IA014

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A043: Identifying tumor heterogeneity and drug sensitivity in primary prostate cancer towards personalized medicine

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.A043-A043

2023

Link zum Volltext

Verfügbarkeit prüfen

Matching single cells across modalities with contrastive learning and optimal transport

Briefings in bioinformatics, 2023-05, Vol.24 (3)

2023

Link zum Volltext

Verfügbarkeit prüfen

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial

BMC urology, 2023-05, Vol.23 (1), p.89-89, Article 89

2023

Link zum Volltext

Verfügbarkeit prüfen

Bladder cancer organoids as a functional system to model different disease stages and therapy response

Nature communications, 2023-04, Vol.14 (1), p.2214-2214, Article 2214

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 22: A new transgenic mouse model to explore the role of Cripto signaling in lethal prostate cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.22-22

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 182: Bladder cancer organoids as a functional system to model different disease stages and therapy response

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.182-182

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.9041-9054

2023

Link zum Volltext

Verfügbarkeit prüfen

Epiregulin expression and secretion is increased in castration-resistant prostate cancer

Frontiers in oncology, 2023-03, Vol.13, p.1107021-1107021

2023

Link zum Volltext

Verfügbarkeit prüfen

Exploring prostate cancer in the post-genomic era

Cancer letters, 2023-01, Vol.553, p.215992-215992, Article 215992

2023

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

European urology open science (Online), 2022-10, Vol.44, p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Featuring the guest editors for the Special Issue on Prostate Cancer, Cancer Letters

Cancer letters, 2022-09, Vol.544, p.215807-215807, Article 215807

2022

Link zum Volltext

Verfügbarkeit prüfen

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

Cancers, 2022-08, Vol.14 (15), p.3758

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)

Publikationsform

Artikel
(121)
Tagungsberichte
(1)

Sprache

Englisch
(122)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(62)
Humans
(29)
Prostate Cancer
(29)
Oncology
(28)
Animals
(24)
Tumors
(21)
Male
(20)
Metastasis
(16)
Mice
(16)
Multidisciplinary Sciences
(13)
Science & Technology - Other Topics
(13)
Cell Biology
(11)
Organoids
(11)
Cell Line, Tumor
(10)
Gene Expression
(10)
Cancer
(9)
Cell Proliferation
(9)
Medical Research
(9)
Stem Cells
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Overcoming limitations in current measures of drug response may enable AI-driven precision oncology

ScLinear predicts protein abundance at single-cell resolution

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer

Editorial: Mechanisms of microenvironment governed plasticity and progression in solid tumors

Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness

Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells

Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union

Minor intron splicing is critical for survival of lethal prostate cancer

Tumour mutations in long noncoding RNAs enhance cell fitness

Abstract A044: Generation of a new mouse model to study the role of oncofetal Cripto in aggressive lethal prostate cancer

Abstract B008: Tumor-stromal 3D co-cultures to study the role of cancer-associated fibroblasts in the acquisition of androgen-deprivation therapy resistance in prostate cancer

Abstract B007: New generation mTOR blocker sensitizes prostate cancer models to AR-targeting therapy

Abstract IA014: Drug sensitivity of multifocal primary prostate cancer

Abstract A043: Identifying tumor heterogeneity and drug sensitivity in primary prostate cancer towards personalized medicine

Matching single cells across modalities with contrastive learning and optimal transport

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial

Bladder cancer organoids as a functional system to model different disease stages and therapy response

Abstract 22: A new transgenic mouse model to explore the role of Cripto signaling in lethal prostate cancer

Abstract 182: Bladder cancer organoids as a functional system to model different disease stages and therapy response

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

Epiregulin expression and secretion is increased in castration-resistant prostate cancer

Exploring prostate cancer in the post-genomic era

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

Featuring the guest editors for the Special Issue on Prostate Cancer, Cancer Letters

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

Aktive Filter

Suchergebnisse filtern